MedNews — All News
Children Still At Risk from Lead Poisoning, Despite Programs Promoting Cleaning and Home Repair
A review of studies shows that children are still at risk of lead poisoning, despite attempts to encourage home cleaning and repairs, and parental awareness. More »
Sports and Exercise Reduces Breast Cancer Rates
Women who actively participate in sports are 25% less likely to get breast cancer, though the benefits are not seen in obese women, and lean women see the lowest breast cancer rates.
The type of activity undertaken, at what time in life and the woman’s body mass index (BMI) will determine how protective the activity is against the disease. More »
FDA Approves NovoSeven RT Coagulation Therapy
A new formulation of a genetically engineered version of Factor VIIa, a plasma protein essential for the clotting of blood—has been approved by the FDA. The new formulation allows the product to be stored at room temperature (up to 77 degrees Fahrenheit) for up to two years. More »
Alzheimer's Disease Risk Different for Men and Women
Recent research suggests that the chances of developing Alzheimer's Disease are different for men and women, with stroke in men and depression in women being key elements.
The research was conducted in France, among 7,000 people aged 65 and over, drawn from the general population. While none of the participants had dementia, some 40% had mild cognitive impairment. Four years later 6.5% of those displaying mild cognitive impairment had developed dementia, while no change was noted in just over half. About one third returned to normal cognitive ability. More »
Gene Linked to Severe Diabetic Retinopathy and Renal Disease
Researchers have identified a gene called erythropoietin (EPO) that is linked to higher risk of severe retinopathy and nephropathy, eye and kidney diseases that often affect diabetic patients.
Diabetic retinopathy (PDR) is the most common cause of legal blindness in working-aged adults in the United States, accounting for 10% of new cases of blindness. Diabetes is also the leading cause of kidney disease, called end-stage renal disease (ESRD), in the U.S. and the Western world. More »
New Crohn's Disease Treatment Approved by FDA
The U.S. Food and Drug Administration (FDA) has approved a new medicine called Cimzia for the treatment of Chron's disease. The drug is manufactured by UCB, Inc., and is known as a tumor necrosis factor (TNF) blocker. It is used to reduce the signs and symptoms of moderately to severely active Crohn's disease in adult patients who have not been helped enough by usual treatments. More »
New Study Begins for Kids with High Risk Cancer, Neuroblastoma
Molecular Insight Pharmaceuticals has announced the initiation of a clinical trial of Azedra in pediatric neuroblastoma patients. Neuroblastoma is a type of neuroendocrine cancer that primarily affects children and is the most common solid tumor in children outside of the brain. More »
Usage of Testicular Cancer Markers Too Limited, Say Researchers
A standard part of testicular cancer care isn't used in more than half of all patients who have the condition, researchers have found.
Doctors generally rely on a series of three serum-based tumor markers for testicular cancer, since these are helpful with diagnosis, prognostication and surveillance for disease recurrence following treatment. More »
